•
Dec 31, 2012

ResMed Q2 2013 Earnings Report

Total Revenue
$377M
Previous year: $333M
+13.2%
EPS
$0.53
Previous year: $0.42
+26.2%
Gross Profit
$233M
Previous year: $199M
+17.1%
Cash and Equivalents
$958M
Previous year: $723M
+32.5%
Free Cash Flow
$79.8M
Previous year: $98.3M
-18.8%
Total Assets
$2.33B
Previous year: $2.04B
+14.2%

ResMed

ResMed